News

The prospective, multi-center, single arm trial is designed to assess the safety and efficacy of SELUTION SLR™ Drug-Eluting Balloon (DEB) for the endovascular therapy of de novo and non-stented restenotic lesions in the superficial femoral...

Dr. Chan’s winning submission, “Socioeconomic disparities and the prognostic value of coronary inflammatory risk from routine coronary CT angiography: The Oxford Risk Factors and Non-Invasive Imaging (ORFAN) study,” investigates the...

JACC Incoming Editor-in-Chief Harlan M. Krumholz, MD, SM, FACC, said, the goal of the report card is to promote accountability and catalyze action that finally addresses this national tragedy. “Our study reveals that Black Americans, because...

“The sobering reality is that many of these amputations can be prevented with early detection. Understanding risk factors, and symptoms and working collaboratively with other disciplines is key. Through the MISA initiative, we want to promote...

Prior to this trial, international guidelines stated that preoxygenation with either noninvasive ventilation or an oxygen mask is acceptable – guidance that results of this trial are likely to change. "Our study found that among critically...

“Climate change is already affecting our cardiovascular health; exposure to extreme heat can adversely affect heart rate and blood pressure; exposure to ozone or wildfire smog can trigger systemic inflammation; living through a natural...

Anteris Technologies Ltd, a structural heart company developing DurAVR THV, a balloon-expandable, single-piece biomimetic aortic replacement valve shaped to mimic the native human valve, announced a summation of the Company’s presentation at...